Roche’s Tecentriq Glows In Pivotal Trial For Early Lung Cancer

Immunotherapy Improves DFS In Early NSCLC

 
• By Sten Stovall
  
IMPower010 Met Its Endpoint of Disease-Free Survival At Interim Analysis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D